Galera Therapeutics, Inc. (GRTX)
OTCMKTS · Delayed Price · Currency is USD
0.0890
+0.0009 (1.02%)
At close: Jul 7, 2026
Galera Therapeutics Market Cap
Galera Therapeutics has a market cap or net worth of $14.28 million as of July 7, 2026. Its market cap has increased by 588.04% in one year.
Market Cap
14.28M
Enterprise Value
13.07M
Revenue
n/a
Ranking
n/a
PE Ratio
0.14
Stock Price
$0.09
Market Cap Chart
Since November 7, 2019, Galera Therapeutics's market cap has decreased from 292.35M to 14.28M, a decrease of -95.12%. That is a compound annual growth rate of -36.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 14.28M | 760.05% |
| Dec 31, 2025 | 1.66M | -51.98% |
| Dec 31, 2024 | 3.46M | -56.28% |
| Dec 29, 2023 | 7.91M | -81.38% |
| Dec 30, 2022 | 42.47M | -65.01% |
| Dec 31, 2021 | 121.35M | -52.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oncotelic Therapeutics | 18.22M |
| Finch Therapeutics Group | 16.86M |
| Zenith Capital | 15.97M |
| Brainstorm Cell Therapeutics | 15.89M |
| Anebulo Pharmaceuticals | 15.50M |
| Zeo ScientifiX | 14.89M |
| Inhibitor Therapeutics | 13.75M |
| LianBio | 12.44M |